nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—Epinephrine—Methyldopa—hypertension	0.168	1	CrCrCtD
Dipivefrin—ADRA2B—hypertension	0.131	0.412	CbGaD
Dipivefrin—ADRA1A—hypertension	0.0809	0.255	CbGaD
Dipivefrin—ADRA2A—hypertension	0.0572	0.181	CbGaD
Dipivefrin—ADRB2—hypertension	0.0481	0.152	CbGaD
Dipivefrin—ADRB2—Esmolol—hypertension	0.0205	0.0519	CbGbCtD
Dipivefrin—ADRA2C—Guanabenz—hypertension	0.0163	0.0411	CbGbCtD
Dipivefrin—ADRB2—Nebivolol—hypertension	0.0155	0.0393	CbGbCtD
Dipivefrin—ADRB2—Labetalol—hypertension	0.0155	0.0393	CbGbCtD
Dipivefrin—ADRB2—Nadolol—hypertension	0.0155	0.0393	CbGbCtD
Dipivefrin—ADRA2B—Guanabenz—hypertension	0.0154	0.039	CbGbCtD
Dipivefrin—ADRA2B—Guanfacine—hypertension	0.0143	0.0362	CbGbCtD
Dipivefrin—ADRB2—Acebutolol—hypertension	0.0142	0.036	CbGbCtD
Dipivefrin—ADRB2—Metoprolol—hypertension	0.0132	0.0334	CbGbCtD
Dipivefrin—ADRB2—Pindolol—hypertension	0.0132	0.0334	CbGbCtD
Dipivefrin—ADRA2C—Fenoldopam—hypertension	0.0128	0.0325	CbGbCtD
Dipivefrin—ADRA2B—Fenoldopam—hypertension	0.0122	0.0308	CbGbCtD
Dipivefrin—ADRB2—Betaxolol—hypertension	0.0118	0.0298	CbGbCtD
Dipivefrin—ADRA2A—Methyldopa—hypertension	0.0117	0.0296	CbGbCtD
Dipivefrin—BCHE—Perindopril—hypertension	0.0113	0.0286	CbGbCtD
Dipivefrin—ADRB2—Penbutolol—hypertension	0.0108	0.0273	CbGbCtD
Dipivefrin—ADRA2A—Guanabenz—hypertension	0.0107	0.0271	CbGbCtD
Dipivefrin—ADRA2A—Guanfacine—hypertension	0.00997	0.0252	CbGbCtD
Dipivefrin—BCHE—Ramipril—hypertension	0.00936	0.0237	CbGbCtD
Dipivefrin—ADRA2B—Prazosin—hypertension	0.00924	0.0234	CbGbCtD
Dipivefrin—ADRA1A—Terazosin—hypertension	0.00899	0.0227	CbGbCtD
Dipivefrin—ADRA2A—Fenoldopam—hypertension	0.00848	0.0214	CbGbCtD
Dipivefrin—ADRA2C—Carvedilol—hypertension	0.0084	0.0213	CbGbCtD
Dipivefrin—ADRA1A—Fenoldopam—hypertension	0.00813	0.0206	CbGbCtD
Dipivefrin—ADRA2B—Carvedilol—hypertension	0.00797	0.0202	CbGbCtD
Dipivefrin—ADRA2A—Doxazosin—hypertension	0.00782	0.0198	CbGbCtD
Dipivefrin—ADRB2—Timolol—hypertension	0.00759	0.0192	CbGbCtD
Dipivefrin—ADRA1A—Doxazosin—hypertension	0.0075	0.019	CbGbCtD
Dipivefrin—ADRA2C—Clonidine—hypertension	0.00738	0.0187	CbGbCtD
Dipivefrin—ADRB2—Carvedilol—hypertension	0.00735	0.0186	CbGbCtD
Dipivefrin—ADRA2B—Clonidine—hypertension	0.007	0.0177	CbGbCtD
Dipivefrin—ADRB2—Propranolol—hypertension	0.00677	0.0171	CbGbCtD
Dipivefrin—ADRA2A—Prazosin—hypertension	0.00642	0.0162	CbGbCtD
Dipivefrin—ADRA1A—Prazosin—hypertension	0.00616	0.0156	CbGbCtD
Dipivefrin—ADRA2A—Carvedilol—hypertension	0.00554	0.014	CbGbCtD
Dipivefrin—ADRA1A—Carvedilol—hypertension	0.00532	0.0134	CbGbCtD
Dipivefrin—ADRA1A—Nicardipine—hypertension	0.00532	0.0134	CbGbCtD
Dipivefrin—ADRA2A—Clonidine—hypertension	0.00487	0.0123	CbGbCtD
Dipivefrin—ADRA1A—Clonidine—hypertension	0.00467	0.0118	CbGbCtD
Dipivefrin—Mydriasis—Mecamylamine—hypertension	0.00165	0.0382	CcSEcCtD
Dipivefrin—ADRB2—Treprostinil—Nadolol—hypertension	0.00079	1	CbGdCrCtD
Dipivefrin—Epinephrine—ADRBK1—hypertension	0.000592	0.277	CrCbGaD
Dipivefrin—Bambuterol—ADRB2—hypertension	0.000542	0.254	CrCbGaD
Dipivefrin—Stinging—Hydrochlorothiazide—hypertension	0.000508	0.0118	CcSEcCtD
Dipivefrin—Arrhythmia—Reserpine—hypertension	0.00049	0.0113	CcSEcCtD
Dipivefrin—Stinging—Losartan—hypertension	0.000482	0.0112	CcSEcCtD
Dipivefrin—Conjunctivitis—Hydralazine—hypertension	0.000442	0.0102	CcSEcCtD
Dipivefrin—Conjunctivitis—Pindolol—hypertension	0.000436	0.0101	CcSEcCtD
Dipivefrin—Conjunctivitis—Nadolol—hypertension	0.00042	0.00972	CcSEcCtD
Dipivefrin—Arrhythmia—Chlorthalidone—hypertension	0.000415	0.00961	CcSEcCtD
Dipivefrin—Conjunctivitis—Guanfacine—hypertension	0.000412	0.00954	CcSEcCtD
Dipivefrin—Conjunctivitis—Nicardipine—hypertension	0.000411	0.0095	CcSEcCtD
Dipivefrin—Stinging—Timolol—hypertension	0.000404	0.00936	CcSEcCtD
Dipivefrin—Conjunctivitis—Terazosin—hypertension	0.000391	0.00905	CcSEcCtD
Dipivefrin—Arrhythmia—Bepridil—hypertension	0.00039	0.00902	CcSEcCtD
Dipivefrin—Conjunctivitis—Acebutolol—hypertension	0.000381	0.00882	CcSEcCtD
Dipivefrin—Tachycardia—Fenoldopam—hypertension	0.000367	0.00849	CcSEcCtD
Dipivefrin—Conjunctivitis—Eprosartan—hypertension	0.000366	0.00847	CcSEcCtD
Dipivefrin—Conjunctivitis—Nisoldipine—hypertension	0.000356	0.00822	CcSEcCtD
Dipivefrin—Conjunctivitis—Amlodipine—hypertension	0.000356	0.00822	CcSEcCtD
Dipivefrin—Arrhythmia—Quinapril—hypertension	0.000354	0.00818	CcSEcCtD
Dipivefrin—Arrhythmia—Benazepril—hypertension	0.000348	0.00805	CcSEcCtD
Dipivefrin—Hypersensitivity—Triamterene—hypertension	0.000341	0.00788	CcSEcCtD
Dipivefrin—Arrhythmia—Felodipine—hypertension	0.000335	0.00776	CcSEcCtD
Dipivefrin—Conjunctivitis—Metoprolol—hypertension	0.000334	0.00773	CcSEcCtD
Dipivefrin—Pain—Ethacrynic acid—hypertension	0.000333	0.00771	CcSEcCtD
Dipivefrin—Pain—Reserpine—hypertension	0.000333	0.00771	CcSEcCtD
Dipivefrin—Hypertension—Bepridil—hypertension	0.000328	0.00759	CcSEcCtD
Dipivefrin—Arrhythmia—Terazosin—hypertension	0.000323	0.00747	CcSEcCtD
Dipivefrin—Tachycardia—Prazosin—hypertension	0.00032	0.00741	CcSEcCtD
Dipivefrin—Hypertension—Candesartan—hypertension	0.000317	0.00733	CcSEcCtD
Dipivefrin—Epinephrine—ADRA2B—hypertension	0.000305	0.143	CrCbGaD
Dipivefrin—Conjunctivitis—Diltiazem—hypertension	0.000297	0.00687	CcSEcCtD
Dipivefrin—Conjunctivitis—Indapamide—hypertension	0.000297	0.00687	CcSEcCtD
Dipivefrin—Pain—Torasemide—hypertension	0.000296	0.00684	CcSEcCtD
Dipivefrin—Hypersensitivity—Hydroflumethiazide—hypertension	0.000295	0.00684	CcSEcCtD
Dipivefrin—Arrhythmia—Amlodipine—hypertension	0.000293	0.00679	CcSEcCtD
Dipivefrin—Tachycardia—Candesartan—hypertension	0.000292	0.00676	CcSEcCtD
Dipivefrin—Hypertension—Nadolol—hypertension	0.000292	0.00675	CcSEcCtD
Dipivefrin—Conjunctivitis—Doxazosin—hypertension	0.000291	0.00673	CcSEcCtD
Dipivefrin—Hypertension—Guanfacine—hypertension	0.000286	0.00662	CcSEcCtD
Dipivefrin—Hypertension—Nicardipine—hypertension	0.000285	0.0066	CcSEcCtD
Dipivefrin—Conjunctivitis—Nifedipine—hypertension	0.000283	0.00656	CcSEcCtD
Dipivefrin—Tachycardia—Hydralazine—hypertension	0.000283	0.00655	CcSEcCtD
Dipivefrin—Hypertension—Metolazone—hypertension	0.000282	0.00652	CcSEcCtD
Dipivefrin—Pain—Prazosin—hypertension	0.000281	0.00649	CcSEcCtD
Dipivefrin—Tachycardia—Pindolol—hypertension	0.000279	0.00646	CcSEcCtD
Dipivefrin—Arrhythmia—Metoprolol—hypertension	0.000276	0.00638	CcSEcCtD
Dipivefrin—Tachycardia—Quinapril—hypertension	0.000275	0.00635	CcSEcCtD
Dipivefrin—Hypersensitivity—Nebivolol—hypertension	0.00027	0.00625	CcSEcCtD
Dipivefrin—Pain—Bepridil—hypertension	0.000265	0.00614	CcSEcCtD
Dipivefrin—Tachycardia—Isradipine—hypertension	0.000265	0.00613	CcSEcCtD
Dipivefrin—Tachycardia—Guanfacine—hypertension	0.000264	0.00611	CcSEcCtD
Dipivefrin—Tachycardia—Nicardipine—hypertension	0.000263	0.00609	CcSEcCtD
Dipivefrin—Pain—Penbutolol—hypertension	0.000263	0.00607	CcSEcCtD
Dipivefrin—Hypertension—Labetalol—hypertension	0.000262	0.00607	CcSEcCtD
Dipivefrin—Tachycardia—Felodipine—hypertension	0.00026	0.00602	CcSEcCtD
Dipivefrin—Tachycardia—Terazosin—hypertension	0.000251	0.0058	CcSEcCtD
Dipivefrin—Hypersensitivity—Chlorothiazide—hypertension	0.000248	0.00574	CcSEcCtD
Dipivefrin—Pain—Amiloride—hypertension	0.000248	0.00574	CcSEcCtD
Dipivefrin—Arrhythmia—Indapamide—hypertension	0.000245	0.00567	CcSEcCtD
Dipivefrin—Arrhythmia—Diltiazem—hypertension	0.000245	0.00567	CcSEcCtD
Dipivefrin—Pain—Pindolol—hypertension	0.000245	0.00566	CcSEcCtD
Dipivefrin—Conjunctivitis—Enalapril—hypertension	0.000243	0.00563	CcSEcCtD
Dipivefrin—Hypersensitivity—Chlorthalidone—hypertension	0.000243	0.00563	CcSEcCtD
Dipivefrin—Hypersensitivity—Prazosin—hypertension	0.000242	0.00559	CcSEcCtD
Dipivefrin—Conjunctivitis—Telmisartan—hypertension	0.00024	0.00555	CcSEcCtD
Dipivefrin—Arrhythmia—Doxazosin—hypertension	0.00024	0.00555	CcSEcCtD
Dipivefrin—Arrhythmia—Fosinopril—hypertension	0.000237	0.00548	CcSEcCtD
Dipivefrin—Pain—Nadolol—hypertension	0.000236	0.00546	CcSEcCtD
Dipivefrin—Tachycardia—Eprosartan—hypertension	0.000234	0.00542	CcSEcCtD
Dipivefrin—Arrhythmia—Nifedipine—hypertension	0.000234	0.00541	CcSEcCtD
Dipivefrin—Hypertension—Metoprolol—hypertension	0.000232	0.00537	CcSEcCtD
Dipivefrin—Hypertension—Guanabenz—hypertension	0.000232	0.00537	CcSEcCtD
Dipivefrin—Pain—Nicardipine—hypertension	0.00023	0.00533	CcSEcCtD
Dipivefrin—Pain—Metolazone—hypertension	0.000228	0.00527	CcSEcCtD
Dipivefrin—Tachycardia—Amlodipine—hypertension	0.000228	0.00527	CcSEcCtD
Dipivefrin—Tachycardia—Nisoldipine—hypertension	0.000228	0.00527	CcSEcCtD
Dipivefrin—Conjunctivitis—Perindopril—hypertension	0.000227	0.00524	CcSEcCtD
Dipivefrin—Conjunctivitis—Irbesartan—hypertension	0.000226	0.00522	CcSEcCtD
Dipivefrin—Conjunctivitis—Hydrochlorothiazide—hypertension	0.000224	0.00518	CcSEcCtD
Dipivefrin—Pain—Esmolol—hypertension	0.000222	0.00515	CcSEcCtD
Dipivefrin—Pain—Terazosin—hypertension	0.00022	0.00508	CcSEcCtD
Dipivefrin—Conjunctivitis—Betaxolol—hypertension	0.000218	0.00504	CcSEcCtD
Dipivefrin—Hypersensitivity—Methyldopa—hypertension	0.000218	0.00503	CcSEcCtD
Dipivefrin—Arrhythmia—Olmesartan—hypertension	0.000216	0.00499	CcSEcCtD
Dipivefrin—Pain—Acebutolol—hypertension	0.000214	0.00495	CcSEcCtD
Dipivefrin—Tachycardia—Guanabenz—hypertension	0.000214	0.00495	CcSEcCtD
Dipivefrin—Tachycardia—Metoprolol—hypertension	0.000214	0.00495	CcSEcCtD
Dipivefrin—Hypersensitivity—Hydralazine—hypertension	0.000214	0.00494	CcSEcCtD
Dipivefrin—Conjunctivitis—Losartan—hypertension	0.000213	0.00492	CcSEcCtD
Dipivefrin—Pain—Labetalol—hypertension	0.000212	0.00491	CcSEcCtD
Dipivefrin—Arrhythmia—Clonidine—hypertension	0.000207	0.00478	CcSEcCtD
Dipivefrin—Pain—Eprosartan—hypertension	0.000205	0.00475	CcSEcCtD
Dipivefrin—Hypertension—Carvedilol—hypertension	0.000204	0.00472	CcSEcCtD
Dipivefrin—Hypersensitivity—Benazepril—hypertension	0.000204	0.00472	CcSEcCtD
Dipivefrin—Hypertension—Doxazosin—hypertension	0.000202	0.00467	CcSEcCtD
Dipivefrin—Arrhythmia—Trandolapril—hypertension	0.000202	0.00466	CcSEcCtD
Dipivefrin—Arrhythmia—Enalapril—hypertension	0.000201	0.00464	CcSEcCtD
Dipivefrin—Pain—Amlodipine—hypertension	0.000199	0.00461	CcSEcCtD
Dipivefrin—Hypertension—Fosinopril—hypertension	0.000199	0.00461	CcSEcCtD
Dipivefrin—Hypersensitivity—Guanfacine—hypertension	0.000199	0.00461	CcSEcCtD
Dipivefrin—Hypersensitivity—Nicardipine—hypertension	0.000199	0.00459	CcSEcCtD
Dipivefrin—Arrhythmia—Telmisartan—hypertension	0.000198	0.00458	CcSEcCtD
Dipivefrin—Hypersensitivity—Metolazone—hypertension	0.000196	0.00454	CcSEcCtD
Dipivefrin—Hypersensitivity—Felodipine—hypertension	0.000196	0.00454	CcSEcCtD
Dipivefrin—Hypertension—Verapamil—hypertension	0.000196	0.00453	CcSEcCtD
Dipivefrin—Hypersensitivity—Spironolactone—hypertension	0.000196	0.00453	CcSEcCtD
Dipivefrin—ACHE—heart—hypertension	0.000194	0.0516	CbGeAlD
Dipivefrin—Tachycardia—Indapamide—hypertension	0.00019	0.0044	CcSEcCtD
Dipivefrin—Tachycardia—Diltiazem—hypertension	0.00019	0.0044	CcSEcCtD
Dipivefrin—Hypersensitivity—Terazosin—hypertension	0.000189	0.00438	CcSEcCtD
Dipivefrin—Epinephrine—ADRA1A—hypertension	0.000189	0.0885	CrCbGaD
Dipivefrin—Tachycardia—Carvedilol—hypertension	0.000188	0.00436	CcSEcCtD
Dipivefrin—Pain—Guanabenz—hypertension	0.000187	0.00434	CcSEcCtD
Dipivefrin—Pain—Metoprolol—hypertension	0.000187	0.00434	CcSEcCtD
Dipivefrin—Arrhythmia—Perindopril—hypertension	0.000187	0.00432	CcSEcCtD
Dipivefrin—Arrhythmia—Irbesartan—hypertension	0.000186	0.00431	CcSEcCtD
Dipivefrin—Tachycardia—Doxazosin—hypertension	0.000186	0.00431	CcSEcCtD
Dipivefrin—Arrhythmia—Hydrochlorothiazide—hypertension	0.000185	0.00427	CcSEcCtD
Dipivefrin—Tachycardia—Fosinopril—hypertension	0.000184	0.00426	CcSEcCtD
Dipivefrin—Hypersensitivity—Labetalol—hypertension	0.000183	0.00423	CcSEcCtD
Dipivefrin—Conjunctivitis—Ramipril—hypertension	0.000182	0.00422	CcSEcCtD
Dipivefrin—Arrhythmia—Furosemide—hypertension	0.000182	0.0042	CcSEcCtD
Dipivefrin—Tachycardia—Nifedipine—hypertension	0.000182	0.0042	CcSEcCtD
Dipivefrin—Tachycardia—Verapamil—hypertension	0.000181	0.00418	CcSEcCtD
Dipivefrin—Arrhythmia—Betaxolol—hypertension	0.00018	0.00416	CcSEcCtD
Dipivefrin—Conjunctivitis—Timolol—hypertension	0.000178	0.00412	CcSEcCtD
Dipivefrin—Hypersensitivity—Eprosartan—hypertension	0.000177	0.00409	CcSEcCtD
Dipivefrin—Arrhythmia—Losartan—hypertension	0.000175	0.00406	CcSEcCtD
Dipivefrin—Pain—Propranolol—hypertension	0.000172	0.00398	CcSEcCtD
Dipivefrin—Hypersensitivity—Nisoldipine—hypertension	0.000172	0.00398	CcSEcCtD
Dipivefrin—Hypersensitivity—Amlodipine—hypertension	0.000172	0.00398	CcSEcCtD
Dipivefrin—Tachycardia—Olmesartan—hypertension	0.000167	0.00387	CcSEcCtD
Dipivefrin—Pain—Diltiazem—hypertension	0.000167	0.00386	CcSEcCtD
Dipivefrin—Pain—Indapamide—hypertension	0.000167	0.00386	CcSEcCtD
Dipivefrin—Hypertension—Telmisartan—hypertension	0.000167	0.00385	CcSEcCtD
Dipivefrin—Pain—Carvedilol—hypertension	0.000165	0.00382	CcSEcCtD
Dipivefrin—Pain—Doxazosin—hypertension	0.000163	0.00378	CcSEcCtD
Dipivefrin—Hypersensitivity—Guanabenz—hypertension	0.000162	0.00374	CcSEcCtD
Dipivefrin—Hypersensitivity—Metoprolol—hypertension	0.000162	0.00374	CcSEcCtD
Dipivefrin—Pain—Fosinopril—hypertension	0.000161	0.00373	CcSEcCtD
Dipivefrin—Tachycardia—Clonidine—hypertension	0.00016	0.00371	CcSEcCtD
Dipivefrin—Pain—Eplerenone—hypertension	0.00016	0.00371	CcSEcCtD
Dipivefrin—Pain—Nifedipine—hypertension	0.000159	0.00368	CcSEcCtD
Dipivefrin—Pain—Verapamil—hypertension	0.000158	0.00366	CcSEcCtD
Dipivefrin—Hypertension—Perindopril—hypertension	0.000157	0.00364	CcSEcCtD
Dipivefrin—ACHE—medulla oblongata—hypertension	0.000157	0.0416	CbGeAlD
Dipivefrin—Hypertension—Irbesartan—hypertension	0.000157	0.00363	CcSEcCtD
Dipivefrin—Tachycardia—Trandolapril—hypertension	0.000156	0.00362	CcSEcCtD
Dipivefrin—ADRA2C—cardiac ventricle—hypertension	0.000156	0.0414	CbGeAlD
Dipivefrin—Tachycardia—Enalapril—hypertension	0.000156	0.0036	CcSEcCtD
Dipivefrin—Tachycardia—Telmisartan—hypertension	0.000154	0.00356	CcSEcCtD
Dipivefrin—Arrhythmia—Ramipril—hypertension	0.00015	0.00348	CcSEcCtD
Dipivefrin—Tachycardia—Captopril—hypertension	0.000149	0.00346	CcSEcCtD
Dipivefrin—Hypersensitivity—Propranolol—hypertension	0.000148	0.00343	CcSEcCtD
Dipivefrin—Arrhythmia—Timolol—hypertension	0.000147	0.0034	CcSEcCtD
Dipivefrin—ADRA2C—myocardium—hypertension	0.000147	0.0389	CbGeAlD
Dipivefrin—Pain—Olmesartan—hypertension	0.000147	0.00339	CcSEcCtD
Dipivefrin—BCHE—cardiac ventricle—hypertension	0.000146	0.0386	CbGeAlD
Dipivefrin—ACHE—adrenal gland—hypertension	0.000145	0.0385	CbGeAlD
Dipivefrin—Tachycardia—Perindopril—hypertension	0.000145	0.00336	CcSEcCtD
Dipivefrin—Tachycardia—Irbesartan—hypertension	0.000145	0.00335	CcSEcCtD
Dipivefrin—Hypersensitivity—Diltiazem—hypertension	0.000144	0.00332	CcSEcCtD
Dipivefrin—Hypersensitivity—Indapamide—hypertension	0.000144	0.00332	CcSEcCtD
Dipivefrin—Tachycardia—Hydrochlorothiazide—hypertension	0.000143	0.00332	CcSEcCtD
Dipivefrin—Hypersensitivity—Carvedilol—hypertension	0.000142	0.00329	CcSEcCtD
Dipivefrin—Hypersensitivity—Doxazosin—hypertension	0.000141	0.00325	CcSEcCtD
Dipivefrin—Pain—Clonidine—hypertension	0.000141	0.00325	CcSEcCtD
Dipivefrin—Tachycardia—Betaxolol—hypertension	0.00014	0.00323	CcSEcCtD
Dipivefrin—Hypersensitivity—Fosinopril—hypertension	0.000139	0.00321	CcSEcCtD
Dipivefrin—Hypersensitivity—Nifedipine—hypertension	0.000137	0.00317	CcSEcCtD
Dipivefrin—Hypersensitivity—Verapamil—hypertension	0.000136	0.00316	CcSEcCtD
Dipivefrin—Arrhythmia—Lisinopril—hypertension	0.000136	0.00315	CcSEcCtD
Dipivefrin—Tachycardia—Losartan—hypertension	0.000136	0.00315	CcSEcCtD
Dipivefrin—Pain—Telmisartan—hypertension	0.000135	0.00312	CcSEcCtD
Dipivefrin—Epinephrine—ADRA2A—hypertension	0.000134	0.0627	CrCbGaD
Dipivefrin—Epinephrine—ADRB1—hypertension	0.000134	0.0626	CrCbGaD
Dipivefrin—Pain—Perindopril—hypertension	0.000127	0.00294	CcSEcCtD
Dipivefrin—Hypersensitivity—Valsartan—hypertension	0.000127	0.00294	CcSEcCtD
Dipivefrin—Epinephrine—TNF—hypertension	0.000127	0.0594	CrCbGaD
Dipivefrin—Pain—Irbesartan—hypertension	0.000127	0.00293	CcSEcCtD
Dipivefrin—Pain—Hydrochlorothiazide—hypertension	0.000126	0.00291	CcSEcCtD
Dipivefrin—ADRA1A—brainstem—hypertension	0.000124	0.033	CbGeAlD
Dipivefrin—Hypertension—Timolol—hypertension	0.000124	0.00286	CcSEcCtD
Dipivefrin—Pain—Furosemide—hypertension	0.000124	0.00286	CcSEcCtD
Dipivefrin—Pain—Betaxolol—hypertension	0.000122	0.00283	CcSEcCtD
Dipivefrin—Hypersensitivity—Clonidine—hypertension	0.000121	0.0028	CcSEcCtD
Dipivefrin—Pain—Losartan—hypertension	0.000119	0.00276	CcSEcCtD
Dipivefrin—Hypersensitivity—Trandolapril—hypertension	0.000118	0.00273	CcSEcCtD
Dipivefrin—Hypersensitivity—Enalapril—hypertension	0.000118	0.00272	CcSEcCtD
Dipivefrin—Tachycardia—Ramipril—hypertension	0.000117	0.0027	CcSEcCtD
Dipivefrin—Hypersensitivity—Telmisartan—hypertension	0.000116	0.00268	CcSEcCtD
Dipivefrin—Epinephrine—ADRB2—hypertension	0.000112	0.0527	CrCbGaD
Dipivefrin—BCHE—brainstem—hypertension	0.000111	0.0293	CbGeAlD
Dipivefrin—Hypersensitivity—Irbesartan—hypertension	0.000109	0.00253	CcSEcCtD
Dipivefrin—Hypersensitivity—Hydrochlorothiazide—hypertension	0.000108	0.0025	CcSEcCtD
Dipivefrin—ADRA2C—nephron tubule—hypertension	0.000108	0.0285	CbGeAlD
Dipivefrin—ADRA1A—heart—hypertension	0.000108	0.0285	CbGeAlD
Dipivefrin—Hypersensitivity—Furosemide—hypertension	0.000106	0.00246	CcSEcCtD
Dipivefrin—ADRA2C—adrenal cortex—hypertension	0.000106	0.0281	CbGeAlD
Dipivefrin—Tachycardia—Lisinopril—hypertension	0.000106	0.00245	CcSEcCtD
Dipivefrin—Hypersensitivity—Betaxolol—hypertension	0.000105	0.00244	CcSEcCtD
Dipivefrin—Hypersensitivity—Losartan—hypertension	0.000103	0.00238	CcSEcCtD
Dipivefrin—ADRA2C—heart—hypertension	0.000102	0.0272	CbGeAlD
Dipivefrin—ADRA1A—cardiovascular system—hypertension	0.000101	0.0269	CbGeAlD
Dipivefrin—BCHE—nephron tubule—hypertension	0.0001	0.0266	CbGeAlD
Dipivefrin—Pain—Timolol—hypertension	0.0001	0.00231	CcSEcCtD
Dipivefrin—ADRA2C—decidua—hypertension	9.96e-05	0.0264	CbGeAlD
Dipivefrin—BCHE—heart—hypertension	9.56e-05	0.0253	CbGeAlD
Dipivefrin—BCHE—smooth muscle tissue—hypertension	9.48e-05	0.0251	CbGeAlD
Dipivefrin—ADRA2C—kidney—hypertension	9.46e-05	0.0251	CbGeAlD
Dipivefrin—Pain—Lisinopril—hypertension	9.27e-05	0.00215	CcSEcCtD
Dipivefrin—ADRA2C—cortex of kidney—hypertension	9.21e-05	0.0244	CbGeAlD
Dipivefrin—BCHE—cardiovascular system—hypertension	9.02e-05	0.0239	CbGeAlD
Dipivefrin—Hypersensitivity—Ramipril—hypertension	8.81e-05	0.00204	CcSEcCtD
Dipivefrin—ADRA2C—cardiac atrium—hypertension	8.76e-05	0.0232	CbGeAlD
Dipivefrin—Hypersensitivity—Timolol—hypertension	8.61e-05	0.00199	CcSEcCtD
Dipivefrin—ADRA2C—medulla oblongata—hypertension	8.26e-05	0.0219	CbGeAlD
Dipivefrin—ADRA2A—heart—hypertension	8.17e-05	0.0217	CbGeAlD
Dipivefrin—BCHE—cardiac atrium—hypertension	8.17e-05	0.0217	CbGeAlD
Dipivefrin—ADRA1A—adrenal gland—hypertension	8.02e-05	0.0213	CbGeAlD
Dipivefrin—Hypersensitivity—Lisinopril—hypertension	7.99e-05	0.00185	CcSEcCtD
Dipivefrin—ADRA2A—decidua—hypertension	7.95e-05	0.0211	CbGeAlD
Dipivefrin—BCHE—medulla oblongata—hypertension	7.71e-05	0.0204	CbGeAlD
Dipivefrin—ADRA2C—adrenal gland—hypertension	7.65e-05	0.0203	CbGeAlD
Dipivefrin—ADRA2A—cortex of kidney—hypertension	7.35e-05	0.0195	CbGeAlD
Dipivefrin—BCHE—adrenal gland—hypertension	7.13e-05	0.0189	CbGeAlD
Dipivefrin—ADRA2A—cardiac atrium—hypertension	6.99e-05	0.0185	CbGeAlD
Dipivefrin—ADRA1A—endocrine gland—hypertension	6.96e-05	0.0185	CbGeAlD
Dipivefrin—ADRA2A—medulla oblongata—hypertension	6.59e-05	0.0175	CbGeAlD
Dipivefrin—ADRA1A—central nervous system—hypertension	6.27e-05	0.0166	CbGeAlD
Dipivefrin—BCHE—endocrine gland—hypertension	6.19e-05	0.0164	CbGeAlD
Dipivefrin—ADRA2A—adrenal gland—hypertension	6.1e-05	0.0162	CbGeAlD
Dipivefrin—ADRA2C—central nervous system—hypertension	5.98e-05	0.0158	CbGeAlD
Dipivefrin—BCHE—central nervous system—hypertension	5.57e-05	0.0148	CbGeAlD
Dipivefrin—ADRA2A—endocrine gland—hypertension	5.29e-05	0.014	CbGeAlD
Dipivefrin—ADRA2A—central nervous system—hypertension	4.77e-05	0.0126	CbGeAlD
Dipivefrin—ADRA2C—Signaling Pathways—CALM1—hypertension	1.64e-06	2.35e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—LEP—hypertension	1.64e-06	2.34e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APOE—hypertension	1.64e-06	2.34e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—YWHAZ—hypertension	1.64e-06	2.33e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—EDN1—hypertension	1.64e-06	2.33e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PRKCB—hypertension	1.63e-06	2.33e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—F2—hypertension	1.63e-06	2.33e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—FN1—hypertension	1.63e-06	2.33e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AGT—hypertension	1.62e-06	2.32e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCL5—hypertension	1.62e-06	2.32e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CAV1—hypertension	1.62e-06	2.32e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APOA1—hypertension	1.62e-06	2.31e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NOTCH1—hypertension	1.62e-06	2.31e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SPP1—hypertension	1.62e-06	2.31e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NGF—hypertension	1.62e-06	2.31e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CXCL8—hypertension	1.61e-06	2.3e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—KDR—hypertension	1.6e-06	2.29e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TP53—hypertension	1.6e-06	2.28e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NOTCH1—hypertension	1.6e-06	2.28e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CALM1—hypertension	1.6e-06	2.28e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—APOE—hypertension	1.59e-06	2.27e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—LPL—hypertension	1.59e-06	2.26e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CAV1—hypertension	1.58e-06	2.25e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—H2AFX—hypertension	1.58e-06	2.25e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCR5—hypertension	1.57e-06	2.25e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PRKCD—hypertension	1.57e-06	2.25e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PDGFRB—hypertension	1.57e-06	2.24e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RPS6KB1—hypertension	1.57e-06	2.24e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—APOA1—hypertension	1.57e-06	2.24e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ADCY5—hypertension	1.55e-06	2.22e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PTGS2—hypertension	1.54e-06	2.2e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PRKCB—hypertension	1.54e-06	2.2e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—FN1—hypertension	1.54e-06	2.2e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—F2—hypertension	1.54e-06	2.2e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PRKCG—hypertension	1.54e-06	2.2e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HTR2A—hypertension	1.54e-06	2.2e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—C3—hypertension	1.54e-06	2.19e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ALB—hypertension	1.53e-06	2.19e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ITGB3—hypertension	1.53e-06	2.19e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PRKCA—hypertension	1.53e-06	2.19e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—YWHAZ—hypertension	1.52e-06	2.17e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NOTCH1—hypertension	1.51e-06	2.16e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PTEN—hypertension	1.51e-06	2.16e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—POMC—hypertension	1.51e-06	2.15e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NGF—hypertension	1.5e-06	2.14e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SPP1—hypertension	1.5e-06	2.14e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—INS—hypertension	1.5e-06	2.14e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PDGFB—hypertension	1.5e-06	2.14e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CXCL8—hypertension	1.5e-06	2.14e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FGFR1—hypertension	1.49e-06	2.12e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—POMC—hypertension	1.49e-06	2.12e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—INS—hypertension	1.48e-06	2.11e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCL2—hypertension	1.47e-06	2.1e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—NOS3—hypertension	1.47e-06	2.09e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PIK3R1—hypertension	1.47e-06	2.09e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HIF1A—hypertension	1.47e-06	2.09e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCR5—hypertension	1.46e-06	2.09e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PRKCD—hypertension	1.46e-06	2.09e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AGT—hypertension	1.46e-06	2.09e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCL2—hypertension	1.45e-06	2.08e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IGF1—hypertension	1.45e-06	2.07e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AKT2—hypertension	1.45e-06	2.07e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—EGFR—hypertension	1.44e-06	2.06e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—EP300—hypertension	1.44e-06	2.06e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CALM1—hypertension	1.44e-06	2.05e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—LEP—hypertension	1.43e-06	2.04e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APOE—hypertension	1.43e-06	2.04e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HTR2A—hypertension	1.43e-06	2.04e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IGF1—hypertension	1.43e-06	2.04e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AKT2—hypertension	1.43e-06	2.04e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—C3—hypertension	1.43e-06	2.04e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—EGFR—hypertension	1.42e-06	2.03e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CAV1—hypertension	1.42e-06	2.02e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APOA1—hypertension	1.42e-06	2.02e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—POMC—hypertension	1.41e-06	2.01e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—KDR—hypertension	1.4e-06	2e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—INS—hypertension	1.4e-06	2e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PDGFB—hypertension	1.39e-06	1.98e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PPARG—hypertension	1.39e-06	1.98e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FGFR1—hypertension	1.38e-06	1.97e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCL2—hypertension	1.38e-06	1.96e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SERPINE1—hypertension	1.38e-06	1.96e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—POMC—hypertension	1.37e-06	1.95e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HIF1A—hypertension	1.36e-06	1.94e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—INS—hypertension	1.36e-06	1.94e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SERPINE1—hypertension	1.36e-06	1.94e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AGT—hypertension	1.36e-06	1.94e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IGF1—hypertension	1.35e-06	1.93e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AKT2—hypertension	1.35e-06	1.93e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—AKT1—hypertension	1.35e-06	1.93e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—F2—hypertension	1.35e-06	1.93e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FN1—hypertension	1.35e-06	1.93e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PRKCB—hypertension	1.35e-06	1.93e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PTEN—hypertension	1.35e-06	1.92e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—EGFR—hypertension	1.35e-06	1.92e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PTGS2—hypertension	1.34e-06	1.92e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CALM1—hypertension	1.33e-06	1.91e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—FGF2—hypertension	1.33e-06	1.9e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APOE—hypertension	1.33e-06	1.9e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—LEP—hypertension	1.33e-06	1.9e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RHOA—hypertension	1.33e-06	1.89e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NOTCH1—hypertension	1.32e-06	1.89e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CAV1—hypertension	1.32e-06	1.88e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APOA1—hypertension	1.31e-06	1.88e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—FGF2—hypertension	1.31e-06	1.88e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PIK3R1—hypertension	1.31e-06	1.87e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NOS3—hypertension	1.31e-06	1.87e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RHOA—hypertension	1.31e-06	1.87e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—KDR—hypertension	1.3e-06	1.86e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PIK3R1—hypertension	1.3e-06	1.85e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NOS3—hypertension	1.3e-06	1.85e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SERPINE1—hypertension	1.29e-06	1.83e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—EP300—hypertension	1.28e-06	1.83e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—F2—hypertension	1.25e-06	1.79e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FN1—hypertension	1.25e-06	1.79e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PRKCB—hypertension	1.25e-06	1.79e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ALB—hypertension	1.25e-06	1.78e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—FGF2—hypertension	1.24e-06	1.78e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RHOA—hypertension	1.24e-06	1.77e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RELA—hypertension	1.24e-06	1.76e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—POMC—hypertension	1.23e-06	1.76e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NOTCH1—hypertension	1.23e-06	1.75e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PIK3R1—hypertension	1.23e-06	1.75e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NOS3—hypertension	1.23e-06	1.75e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—INS—hypertension	1.22e-06	1.75e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RELA—hypertension	1.22e-06	1.74e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MTOR—hypertension	1.21e-06	1.73e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCL2—hypertension	1.2e-06	1.72e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MTOR—hypertension	1.2e-06	1.71e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PIK3R1—hypertension	1.19e-06	1.7e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—NOS3—hypertension	1.19e-06	1.7e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IGF1—hypertension	1.18e-06	1.69e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AKT2—hypertension	1.18e-06	1.69e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—EGFR—hypertension	1.18e-06	1.68e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PTEN—hypertension	1.17e-06	1.67e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CXCL8—hypertension	1.17e-06	1.66e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RELA—hypertension	1.15e-06	1.65e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CXCL8—hypertension	1.15e-06	1.64e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—POMC—hypertension	1.14e-06	1.63e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—INS—hypertension	1.14e-06	1.62e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MTOR—hypertension	1.13e-06	1.62e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AKT1—hypertension	1.13e-06	1.61e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SERPINE1—hypertension	1.12e-06	1.6e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCL2—hypertension	1.12e-06	1.6e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—EP300—hypertension	1.12e-06	1.59e-05	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AKT1—hypertension	1.11e-06	1.59e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—IL6—hypertension	1.11e-06	1.58e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IGF1—hypertension	1.1e-06	1.57e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AKT2—hypertension	1.1e-06	1.57e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—IL6—hypertension	1.09e-06	1.56e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—EGFR—hypertension	1.09e-06	1.56e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PTGS2—hypertension	1.09e-06	1.56e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CXCL8—hypertension	1.09e-06	1.55e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FGF2—hypertension	1.09e-06	1.55e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RHOA—hypertension	1.08e-06	1.55e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PIK3R1—hypertension	1.07e-06	1.53e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NOS3—hypertension	1.07e-06	1.53e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MMP9—hypertension	1.05e-06	1.5e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AKT1—hypertension	1.05e-06	1.5e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CDKN1A—hypertension	1.05e-06	1.5e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PTEN—hypertension	1.05e-06	1.5e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SERPINE1—hypertension	1.04e-06	1.49e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MMP9—hypertension	1.04e-06	1.48e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CDKN1A—hypertension	1.04e-06	1.48e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—IL6—hypertension	1.03e-06	1.48e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PTEN—hypertension	1.03e-06	1.48e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MAPK8—hypertension	1.02e-06	1.46e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AKT1—hypertension	1.02e-06	1.46e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MAPK8—hypertension	1.01e-06	1.44e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FGF2—hypertension	1.01e-06	1.44e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RELA—hypertension	1.01e-06	1.44e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AKT1—hypertension	1.01e-06	1.44e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RHOA—hypertension	1.01e-06	1.44e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—EP300—hypertension	9.99e-07	1.43e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PIK3R1—hypertension	9.96e-07	1.42e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NOS3—hypertension	9.96e-07	1.42e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MTOR—hypertension	9.9e-07	1.41e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—EP300—hypertension	9.86e-07	1.41e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MMP9—hypertension	9.84e-07	1.4e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CDKN1A—hypertension	9.81e-07	1.4e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PTEN—hypertension	9.79e-07	1.4e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SRC—hypertension	9.72e-07	1.39e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SRC—hypertension	9.59e-07	1.37e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MAPK8—hypertension	9.57e-07	1.37e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AKT1—hypertension	9.55e-07	1.36e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CXCL8—hypertension	9.51e-07	1.36e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PTEN—hypertension	9.51e-07	1.36e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—VEGFA—hypertension	9.46e-07	1.35e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RELA—hypertension	9.38e-07	1.34e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—VEGFA—hypertension	9.34e-07	1.33e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—EP300—hypertension	9.33e-07	1.33e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MTOR—hypertension	9.2e-07	1.31e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AKT1—hypertension	9.19e-07	1.31e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SRC—hypertension	9.07e-07	1.3e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—EP300—hypertension	9.07e-07	1.29e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—IL6—hypertension	9.05e-07	1.29e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CXCL8—hypertension	8.84e-07	1.26e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—VEGFA—hypertension	8.84e-07	1.26e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MYC—hypertension	8.71e-07	1.24e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—AKT1—hypertension	8.7e-07	1.24e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TGFB1—hypertension	8.68e-07	1.24e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MMP9—hypertension	8.6e-07	1.23e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MYC—hypertension	8.59e-07	1.23e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TGFB1—hypertension	8.57e-07	1.22e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CDKN1A—hypertension	8.57e-07	1.22e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PTEN—hypertension	8.55e-07	1.22e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AKT1—hypertension	8.54e-07	1.22e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—EGFR—hypertension	8.52e-07	1.22e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—EGFR—hypertension	8.41e-07	1.2e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—IL6—hypertension	8.41e-07	1.2e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MAPK8—hypertension	8.37e-07	1.19e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AKT1—hypertension	8.35e-07	1.19e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—EP300—hypertension	8.16e-07	1.16e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MYC—hypertension	8.13e-07	1.16e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TGFB1—hypertension	8.11e-07	1.16e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MMP9—hypertension	8e-07	1.14e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CDKN1A—hypertension	7.97e-07	1.14e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—EGFR—hypertension	7.95e-07	1.14e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PTEN—hypertension	7.95e-07	1.13e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SRC—hypertension	7.93e-07	1.13e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MAPK8—hypertension	7.78e-07	1.11e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—AKT1—hypertension	7.76e-07	1.11e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AKT1—hypertension	7.75e-07	1.11e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—VEGFA—hypertension	7.73e-07	1.1e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—EP300—hypertension	7.58e-07	1.08e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SRC—hypertension	7.37e-07	1.05e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—VEGFA—hypertension	7.18e-07	1.02e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TP53—hypertension	7.15e-07	1.02e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MYC—hypertension	7.11e-07	1.01e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TGFB1—hypertension	7.09e-07	1.01e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TP53—hypertension	7.06e-07	1.01e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—EGFR—hypertension	6.95e-07	9.92e-06	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—AKT1—hypertension	6.74e-07	9.63e-06	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TP53—hypertension	6.68e-07	9.53e-06	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MYC—hypertension	6.61e-07	9.43e-06	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TGFB1—hypertension	6.59e-07	9.4e-06	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL6—hypertension	6.54e-07	9.34e-06	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL6—hypertension	6.46e-07	9.22e-06	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—EGFR—hypertension	6.46e-07	9.22e-06	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL6—hypertension	6.11e-07	8.72e-06	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AKT1—hypertension	6.04e-07	8.62e-06	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AKT1—hypertension	5.96e-07	8.51e-06	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TP53—hypertension	5.84e-07	8.33e-06	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AKT1—hypertension	5.64e-07	8.05e-06	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AKT1—hypertension	5.48e-07	7.82e-06	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TP53—hypertension	5.42e-07	7.74e-06	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL6—hypertension	5.34e-07	7.63e-06	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL6—hypertension	4.97e-07	7.09e-06	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AKT1—hypertension	4.93e-07	7.04e-06	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AKT1—hypertension	4.58e-07	6.54e-06	CbGpPWpGaD
